Second, MSLN was identified as a tumor-differentiation antigen with an overexpression discovered in multiple cancer types, such as epithelial mesothelioma, pancreatic cancer, and lung adenocarcinoma. The gene discussed is MSLN; the disease is malignant epithelioid mesothelioma.